Skip to content

Viscosupplementation with Hyaluronic Acid is associated with Less Pain and Greater Functional Scores in Comparison with Intra-articular Corticosteroid for the Non-Surgical Management of Subtalar Posttraumatic Osteoarthritis – Randomized Comparative Trial

Viscosupplementation with Hyaluronic Acid is associated with Less Pain and Greater Functional Scores in Comparison with Intra-articular Corticosteroid for the Non-Surgical Management of Subtalar Posttraumatic Osteoarthritis – Randomized Comparative Trial - HA hyaluronic acid

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-59p5xcw
Enrollment
Unknown
Registered
2020-11-25
Start date
2016-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic subtalar osteoarthritis

Interventions

Patients with subtalar osteoarthritis following surgical treatment of calcaneus fractures were randomly assigned to two therapeutic groups. Group I underwent isolated corticosteroid (betamethasone)
Group II, a combination of hyaluronic acid and corticosteroid
and Group III isolated hyaluronic acid. All patients underwent three subtalar intra-articular injections with intervals of one-week. We assessed the visual analog scale of pain (VAS) and the ankle hin
D055676

Sponsors

Instituto Nacional de Traumatologia e Ortopedia
Lead Sponsor

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients older than 18 years, from both sex, with subtalar arthritis, and a minimum follow-up of one year after open surgical reduction and internal fixation for calcaneus fractures were included.

Exclusion criteria

Exclusion criteria: Patients who presented subtalar ankylosis or arthrodesis, history of infection or skin lesion, risk of hypersensitivity to hyaluronic acid or corticosteroids, pregnancy or breastfeeding, rheumatologic conditions, anticoagulant therapy, or intra-articular subtalar procedures such as injections or arthroscopy during the six months prior to the interview were not invited to participate in the study.

Design outcomes

Primary

MeasureTime frame
The observer assessed the Ankle/Hindfoot scores from the American Orthopedic Foot and Ankle Society (AOFAS) in all participants, before the first subtalar injection, and 4, 12, and 24 weeks following the first injection.

Secondary

MeasureTime frame
The observer assessed the Visual Analogue Scale (VAS) of pain scores in all participants, before the first subtalar injection, and 4, 12, and 24 weeks following the first injection.

Countries

Brazil

Contacts

Public ContactHenrique ;Fernanda Mansur;Gomes

Instituto Nacional de Traumatologia e Ortopedia;Instituto Nacional de Traumatologia e Ortopedia

henrimansur@globo.com;fernandafgomesot@gmail.com(+55 21) 2134-5000;2121345000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)